Marco Simonini1, Chiara Lanzani1, Elena Bignami2, Nunzia Casamassima1, Elena Frati2, Roberta Meroni2, Elisabetta Messaggio1, Ottavio Alfieri3, John Hamlyn4, Simon C Body5, C David Collard6, Alberto Zangrillo2, Paolo Manunta1. 1. Chair of Nephrology, Università Vita Salute San Raffaele, Milan, Italy Genomics of Renal Disease and Hypertension Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. 2. Anesthesia and Intensive Care Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy Università Vita Salute San Raffaele, Milan, Italy. 3. Università Vita Salute San Raffaele, Milan, Italy Cardiac Surgery Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. 4. Physiology Department, University of Maryland School of Medicine, Baltimore, MD, USA. 5. Department of Anesthesiology, Perioperative & Pain Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA. 6. Baylor St. Luke's Medical Center, Texas Heart Institute, Houston, TX, USA.
Abstract
BACKGROUND: Acute kidney injury (AKI) is an important complication of cardiac surgery. Recently, elevated levels of endogenous ouabain (EO), an adrenal stress hormone with haemodynamic and renal effects, have been associated with worse renal outcome after cardiac surgery. Our aim was to develop and evaluate a new risk model of AKI using simple preoperative clinical parameters and to investigate the utility of EO. METHODS: The primary outcome was AKI according to Acute Kidney Injury Network stage II or III. We selected the Northern New England Cardiovascular Disease Study Group (NNECDSG) as a reference model. We built a new internal predictive risk model considering common clinical variables (CLIN-RISK), compared this model with the NNECDSG model and determined whether the addition of preoperative plasma EO improved prediction of AKI. RESULTS: All models were tested on >800 patients admitted for elective cardiac surgery in our hospital. Seventy-nine patients developed AKI (9.9%). Preoperative EO levels were strongly associated with the incidence of AKI and clinical complication (total ICU stay and in-hospital mortality). The NNECDSG model was confirmed as a good predictor of AKI (AUC 0.74, comparable to the NNECDSG reference population). Our CLIN-RISK model had improved predictive power for AKI (AUC 0.79, CI 95% 0.73-0.84). Furthermore, addition of preoperative EO levels to both clinical models improved AUC to 0.79 and to 0.83, respectively (ΔAUC +0.05 and +0.04, respectively, P < 0.01). CONCLUSION: In a population where the predictive power of the NNECDSG model was confirmed, CLIN-RISK was more powerful. Both clinical models were further improved by the addition of preoperative plasma EO levels. These new models provide improved predictability of the relative risk for the development of AKI following cardiac surgery and suggest that EO is a marker for renal vascular injury.
BACKGROUND:Acute kidney injury (AKI) is an important complication of cardiac surgery. Recently, elevated levels of endogenous ouabain (EO), an adrenal stress hormone with haemodynamic and renal effects, have been associated with worse renal outcome after cardiac surgery. Our aim was to develop and evaluate a new risk model of AKI using simple preoperative clinical parameters and to investigate the utility of EO. METHODS: The primary outcome was AKI according to Acute Kidney Injury Network stage II or III. We selected the Northern New England Cardiovascular Disease Study Group (NNECDSG) as a reference model. We built a new internal predictive risk model considering common clinical variables (CLIN-RISK), compared this model with the NNECDSG model and determined whether the addition of preoperative plasma EO improved prediction of AKI. RESULTS: All models were tested on >800 patients admitted for elective cardiac surgery in our hospital. Seventy-nine patients developed AKI (9.9%). Preoperative EO levels were strongly associated with the incidence of AKI and clinical complication (total ICU stay and in-hospital mortality). The NNECDSG model was confirmed as a good predictor of AKI (AUC 0.74, comparable to the NNECDSG reference population). Our CLIN-RISK model had improved predictive power for AKI (AUC 0.79, CI 95% 0.73-0.84). Furthermore, addition of preoperative EO levels to both clinical models improved AUC to 0.79 and to 0.83, respectively (ΔAUC +0.05 and +0.04, respectively, P < 0.01). CONCLUSION: In a population where the predictive power of the NNECDSG model was confirmed, CLIN-RISK was more powerful. Both clinical models were further improved by the addition of preoperative plasma EO levels. These new models provide improved predictability of the relative risk for the development of AKI following cardiac surgery and suggest that EO is a marker for renal vascular injury.
Authors: S D Pierdomenico; A Bucci; P Manunta; R Rivera; M Ferrandi; J M Hamlyn; D Lapenna; F Cuccurullo; A Mezzetti Journal: Am J Hypertens Date: 2001-01 Impact factor: 2.689
Authors: Giovanni Mariscalco; Roberto Lorusso; Carmelo Dominici; Attilio Renzulli; Andrea Sala Journal: Ann Thorac Surg Date: 2011-08-27 Impact factor: 4.330
Authors: Elena Bignami; Nunzia Casamassima; Elena Frati; Chiara Lanzani; Laura Corno; Ottavio Alfieri; Stephen Gottlieb; Marco Simonini; Keyur B Shah; Anna Mizzi; Elisabetta Messaggio; Alberto Zangrillo; Mara Ferrandi; Patrizia Ferrari; Giuseppe Bianchi; John M Hamlyn; Paolo Manunta Journal: Crit Care Med Date: 2013-03 Impact factor: 7.598
Authors: Elmar Berendes; Paul Cullen; H Van Aken; Walter Zidek; Michael Erren; Michael Hübschen; Thomas Weber; Stefan Wirtz; Martin Tepel; Michael Walter Journal: Crit Care Med Date: 2003-05 Impact factor: 7.598
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Roberta Meroni; Marco Simonini; Nunzia Casamassima; Elena Bignami; Jay L Koyner Journal: Intensive Care Med Date: 2017-08-29 Impact factor: 17.440
Authors: Felix Kork; Felix Balzer; Claudia D Spies; Klaus-Dieter Wernecke; Adit A Ginde; Joachim Jankowski; Holger K Eltzschig Journal: Anesthesiology Date: 2015-12 Impact factor: 7.892
Authors: Scott M Sutherland; Lakhmir S Chawla; Sandra L Kane-Gill; Raymond K Hsu; Andrew A Kramer; Stuart L Goldstein; John A Kellum; Claudio Ronco; Sean M Bagshaw Journal: Can J Kidney Health Dis Date: 2016-02-26
Authors: Marco Simonini; Simona Pozzoli; Elena Bignami; Nunzia Casamassima; Elisabetta Messaggio; Chiara Lanzani; Elena Frati; Irene Maria Botticelli; Francesco Rotatori; Ottavio Alfieri; Alberto Zangrillo; Paolo Manunta Journal: Biomed Res Int Date: 2015-11-01 Impact factor: 3.411